相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Rola Hammoud et al.
NATURE REVIEWS ENDOCRINOLOGY (2023)
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update
Michael A. Nauck et al.
DIABETES OBESITY & METABOLISM (2021)
Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites
Shara Francesca Rapa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
Jonathan M. Wilson et al.
DIABETES OBESITY & METABOLISM (2020)
Glomerular Filtration Rate, its Association with Risk Factors and Cardiovascular Diseases. The Results of the ESSE-RF-2 Study
Svetlana A. Shalnova et al.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY (2020)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies A Scientific Statement From the American Heart Association
Janani Rangaswami et al.
CIRCULATION (2019)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Francois Mach et al.
ATHEROSCLEROSIS (2019)
Impact of chronic kidney disease on mortality: A nationwide cohort study
Kyeong Min Kim et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2019)
Impact of low-density lipoprotein cholesterol on decline in estimated glomerular filtration rate in apparently healthy young to middle-aged working men
Akihiro Kuma et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population
Kazuhiko Tsuruya et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Elimination and Degradation of Glucagon-like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Patients with End-Stage Renal Disease
Thomas Idorn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Oxidative stress in patients with cardiovascular disease and chronic renal failure
A. Popolo et al.
FREE RADICAL RESEARCH (2013)
Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
Jayanta Gupta et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
Marcello Tonelli et al.
LANCET (2012)
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
George Thomas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension
K. Dimitriadis et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Redox control of renal function and hypertension
Ravi Nistala et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Association between serum resistin and carotid intima media thickness in hypertension patients
Dae Shik Choi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults
Allison A. Ellington et al.
HYPERTENSION (2007)
Plasma resistin levels correlate with determinants of the metabolic syndrome
G. D. Norata et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients
J. Malyszko et al.
TRANSPLANTATION PROCEEDINGS (2006)
Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects
C Tsioufis et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
J Axelsson et al.
KIDNEY INTERNATIONAL (2006)
Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension
C Tsioufis et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease
R Ohmori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
The current biology of resistin
CM Steppan et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects
JJ Meier et al.
DIABETES (2004)
Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance
JV Silha et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Resistin promotes endothelial cell activation - Further evidence of adipokine-endothelial interaction
S Verma et al.
CIRCULATION (2003)
Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients
MG Shlipak et al.
ANNALS OF INTERNAL MEDICINE (2002)
Resistin, central obesity, and type 2 diabetes
CL McTernan et al.
LANCET (2002)
分享论文
